Clinical Trial Update: Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing fludarabine, cyclophosphamide, and rituximab (FCR) versus pentostatin, cyclophosphamide, and rituximab (PCR) in adults with B-cell chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Pentostatin (pentostatin)
• Rituximab (rituximab)

Snippet

Sponsor: US Oncology Research | Conditions: B-Cell Chronic Lymphocytic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2016-11-03